Aducanumab: A Deep Dive into BIIB037 and its Impact A compound, initially known as BIIB037, represents a complex endeavor to treat mild Alzheimer's condition. Created by Biogen, the treatment works by clearing amyloid https://lucdbls092698.aboutyoublog.com/52180715/text